February 18, 2025 Kigali, Rwanda and San Francisco, USA

We are proud to celebrate the RIIO Residency Program for achieving Advanced Accreditation from the Ophthalmology Foundation – the first of its kind in Africa. The award-winning program is led by Dr. Ciku Mathenge, a globally recognized expert Clinician, Researcher and Educator specializing in Ophthalmological Diseases. She is also the President of the African Ophthalmology Council. The RIIO Residency Program is particularly noteworthy for its leadership and pivotal importance to increasing capacity for treating serious eye disease in the African region.

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.